MCL1 and rhabdomyosarcoma: S63845 binds with high affinity specifically to the BH3-binding groove of MCL-1 inducing downstream apoptosis signaling and has shown pre-clinical anti-tumor activity in different malignancies such as rhabdomyosarcoma [37], diffuse large B-cell lymphoma [38] and AML [39].